Lisa Ricciardi | executive |
John Doyle | executive |
Elaine Kim | analyst |
Anthony Caggiano | executive |
Raghuram Selvaraju | analyst |
Daniil Gataulin | analyst |
Hello, and thank you for standing by. At this time, I would like to welcome you to the Cognition Therapeutics Second Quarter 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Tom Johnson. Please go ahead.
Thank you, operator, and good morning, everyone.